Status: Recruiting
Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients
The study investigates the role of echocardiography and of serum biomarkers (NT-proBNP, cardiac Troponin-I) in predicting cardiac injury in a cohort of paediatric oncological patients treated with Anthracycline chemotherapy.
Participants needed: 22
Trial details
Age: 0-18Biological sex: AllType: ObservationalSponsor: IRCCS Burlo GarofoloUpdated: May 9, 2025Locations: 1
Eligibility criteria
Paediatric oncological patients 0-18 years [+2]
Previous anthracycline treatment, bone marrow transplantation or chest radiation [+3]